Advancements in Partial Reprogramming Research

This chapter explores the breakthroughs in partial reprogramming and its therapeutic potential across various diseases, especially glaucoma and eye strokes. A key focus is on tailored approaches for different organs to optimize safety and efficacy, particularly in liver rejuvenation and gene therapy. The conversation also addresses the ethical considerations and debates surrounding the impacts of extracellular matrix degradation on aging and the feasibility of head transplantation.